Claranor SA

Claranor SA specializes in advanced pulsed light and UV decontamination solutions for various industries, ensuring product safety and operational efficiency through innovative technology. Founded in 2004 by François Cazalas and headquartered in Avignon, France, Claranor SA focuses on pulsed light sterilization technology. The company has completed six deals, with the latest being a Series C funding round of EUR 0. 734 mn on May 22, 2012, backed by investors including Demeter IM, Expansinvest, and ID Finance.

Claranor is not known to have subsidiaries or be a subsidiary of another firm. Claranor specializes in pulsed light and UV decontamination solutions, targeting the food and beverage, pharmaceutical, and cosmetic industries. Their compact sterilizers are designed for integration into filling lines, eliminating surface microorganisms in packaging. Their technology enhances product safety while maintaining operational efficiency.

Claranor’s solutions are installed in over 600 locations across 63 countries, catering to major OEMs and producers of bottled beverages and pharmaceuticals. For the most recent year, 2020, Claranor reported revenue of EUR 5,804,577. 10 with an EBITDA of EUR 233,461. 70.

The revenue model is based on the sale of sterilization equipment and related services such as maintenance and training, providing ongoing support to clients. Claranor plans to utilize the EUR 733,585 raised in their Series C funding round to support the development of new products and expand into new markets. They are actively targeting growth in the food and beverage sectors across Asia and North America by 2025. The funding will specifically assist in launching their next-generation sterilization technology aimed at enhancing efficiency in high-speed production environments.